Antibody Against Spike Protein
Lab Reagents
Human IgG antibody Laboratories manufactures the antibody against spike protein reagents distributed by Genprice. The Antibody Against Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Against Group: Spike Protein
SARS-CoV Spike Antibody |
|||
| 3223-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3225-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3225-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
Spike Glycoprotein Antibody (HRP) |
|||
| 20-abx300552 | Abbexa |
|
|
Spike Glycoprotein Antibody (FITC) |
|||
| 20-abx300553 | Abbexa |
|
|
Spike Glycoprotein Antibody (Biotin) |
|||
| 20-abx300554 | Abbexa |
|
|
Spike Glycoprotein Polyclonal Antibody |
|||
| A56214-020 | EpiGentek | 20 ul | Ask for price |
Spike Glycoprotein Polyclonal Antibody |
|||
| A56214-050 | EpiGentek | 50 ul | Ask for price |
Spike Glycoprotein Polyclonal Antibody |
|||
| A56214-100 | EpiGentek | 100 ul | EUR 423.5 |
Spike Glycoprotein Polyclonal Antibody |
|||
| A57201-020 | EpiGentek | 20 ul | EUR 117.7 |
Spike Glycoprotein Polyclonal Antibody |
|||
| A57201-050 | EpiGentek | 50 ul | EUR 302.5 |
Spike Glycoprotein Polyclonal Antibody |
|||
| A57201-100 | EpiGentek | 100 ul | EUR 423.5 |
Spike Glycoprotein Polyclonal Antibody |
|||
| A56214 | EpiGentek |
|
|
Spike Glycoprotein Polyclonal Antibody |
|||
| A57201 | EpiGentek |
|
|
SARS-CoV Spike Protein |
|||
| abx060655-1mg | Abbexa | 1 mg | EUR 2030.4 |
Anti-MERSC-CoV Spike Protein antibody |
|||
| STJ140102 | St John's Laboratory | 150 µg | EUR 277.2 |
|
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases. |
|||
Coronavirus OC43 Spike glycoprotein Antibody |
|||
| 20-abx109271 | Abbexa |
|
|